AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogawa, T.
Right arrow Articles by Uemura, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogawa, T.
Right arrow Articles by Uemura, K.

American Journal of Neuroradiology, Vol 17, Issue 2 345-353, Copyright © 1996 by American Society of Neuroradiology


ARTICLES

Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine

T Ogawa, A Inugami, J Hatazawa, I Kanno, M Murakami, N Yasui, K Mineura and K Uemura
Department of Radiology, Research Institute of Brain and Blood Vessels, Akita University School of Medicine, Japan.

PURPOSE: To evaluate the differences between fludeoxyglucose F 18 (FDG) and L-methyl-11C-methionine (11C-methionine) as tracers for positron emission tomography (PET) in the evaluation of brain tumors. METHODS: We analyzed 10 patients with histologically verified cerebral glioma or meningioma and 1 patient with a neuroradiologic diagnosis of low-grade glioma by using FDG, 11C-methionine, and PET. We qualitatively and quantitatively evaluated the extent and degree of accumulation of FDG and 11C-methionine in the tumor tissue. RESULTS: Although PET with FDG depicted malignant tumors as a hot spot in all cases, it was not able to delineate the extent of the tumor. Conversely, PET with 11C- methionine outlined the tumors as areas of increased accumulation of 11C-methionine, regardless of the degree of malignancy. CONCLUSION: PET with FDG and with 11C-methionine can play complementary roles in the evaluation of brain tumors.


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
T. Kato, J. Shinoda, N. Oka, K. Miwa, N. Nakayama, H. Yano, T. Maruyama, Y. Muragaki, and T. Iwama
Analysis of 11C-methionine Uptake in Low-Grade Gliomas and Correlation with Proliferative Activity
AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1867 - 1871.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. Kato, J. Shinoda, N. Nakayama, K. Miwa, A. Okumura, H. Yano, S. Yoshimura, T. Maruyama, Y. Muragaki, and T. Iwama
Metabolic Assessment of Gliomas Using 11C-Methionine, [18F] Fluorodeoxyglucose, and 11C-Choline Positron-Emission Tomography
AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1176 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
K. Miwa, J. Shinoda, H. Yano, and T. Iwama
Relatively Decreased 11C-Methionine Uptake within the Anaplastic Component of a Mixed-Grade Oligodendroglioma
AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 2005 - 2007.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D S Rosenberg, G Demarquay, A Jouvet, D Le Bars, N Streichenberger, M Sindou, N Kopp, F Mauguiere, and P Ryvlin
[11C]-Methionine PET: dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms
J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1686 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Airley, J. Loncaster, S. Davidson, M. Bromley, S. Roberts, A. Patterson, R. Hunter, I. Stratford, and C. West
Glucose Transporter Glut-1 Expression Correlates with Tumor Hypoxia and Predicts Metastasis-free Survival in Advanced Carcinoma of the Cervix
Clin. Cancer Res., April 1, 2001; 7(4): 928 - 934.
[Abstract] [Full Text]